The arrival of Retatrutide ZPHC, at a strength of 120mg, is creating considerable excitement within the healthcare community. This novel dual GIP and GLP-1 agonist medication suggests to provide notable improvements in weight loss compared to previous therapies. Early research trials have demonstrated substantial declines in here body fat percentag